High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump.
Adult
Male
Middle Aged
Female
Humans
Diabetes Mellitus, Type 1
/ drug therapy
Prospective Studies
Blood Glucose Self-Monitoring
/ methods
Prevalence
Blood Glucose
Insulin
/ therapeutic use
Insulin Infusion Systems
Feeding and Eating Disorders
/ epidemiology
Insulin, Regular, Human
/ therapeutic use
Hypoglycemic Agents
/ therapeutic use
Blood glucose self-monitoring
Diabetes mellitus, Type 1
Diabulimia
Feeding and eating disorders
Insulin infusion systems
Middle aged
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
06
02
2023
revised:
03
03
2023
accepted:
14
03
2023
medline:
16
5
2023
pubmed:
20
3
2023
entrez:
19
3
2023
Statut:
ppublish
Résumé
The aim of this study was to determine the prevalence of likely eating disorders and insulin misuse in a prospective cohort of adults with type 1 diabetes mellitus (T1DM) treated with insulin pump therapy. This prospective study was held at the participants' home. The participants completed the SCOFF questionnaire as well as a question related to insulin misuse. Information about lifestyle, medical history, insulin pump and Continuous Glucose Monitoring (CGM) data were collected. The analysis covered 198 participants with a median age of 51 [95% CI 38; 62] years. The prevalence of likely eating disorders was 21.7% (95% CI 16.3; 28.2) in the study population and 20.6% (95% CI 14.3; 28.6) and 24.2% (95% CI 14.6; 37.0) in males and females respectively. The prevalence of insulin misuse was 39.0% (95% CI 30.8; 47.7). There was no significant difference in prevalence between males and females for likely eating disorders and insulin misuse. The analysis of CGM data revealed no factors related to glycaemic control associated with likely eating disorders. The results of this study indicate that the prevalence of likely eating disorders is high even in a middle-aged population with a T1DM and satisfactory glucose control.
Identifiants
pubmed: 36934794
pii: S0168-8227(23)00105-5
doi: 10.1016/j.diabres.2023.110630
pii:
doi:
Substances chimiques
Blood Glucose
0
Insulin
0
Insulin, Regular, Human
0
Hypoglycemic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110630Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Pauline Périnet-Marquet, Nathalie Arnol, Sophie Logerot and Jean-Christian Borel were employed by AGIR à Dom at the time the study was conducted. Cécile Bétry has received fees for presenting from AGIR à Dom. Sylvain Iceta has received research grants from Takeda and Diabetes Canada; has been a consultant or member on advisory panels for Takeda and Bausch Health.].